Torisel is a medicine used to treat patients with the following types of cancer: - advanced renal cell carcinoma (a kidney cancer). ‘Advanced’ means that the cancer has started to spread; - mantle cell lymphoma (a cancer of B cells, a type of white blood cell). Torisel is used in adults when the lymphoma has come back after previous treatment or if other treatments have not worked. These diseases are rare, and Torisel was designated an ‘orphan medicine’ (a medicine used in rare diseases) on various dates. Torisel contains the active substance temsirolimus.
Therapeutic Indication
### Therapeutic indication **Renal-cell carcinoma** Torisel is indicated for the first-line treatment of adult patients with advanced renal-cell carcinoma (RCC) who have at least three of six prognostic risk factors. **Mantle-cell lymphoma** Torisel is indicated for the treatment of adult patients with relapsed and / or refractory mantle-cell lymphoma (MCL).
Therapeutic Area (MeSH)
ATC Code
L01XE09
ATC Item
xl 01 xe 09
Pharmacotherapeutic Group
Antineoplastic agents
Active Substance (Summary)
INN / Common Names
EMA Name
Torisel
Medicine Name
Torisel
Aliases
N/ANo risk management plan link.
